Administering therapeutic moiety via the pulmonary route signifies a leading contest in pulmonary medicine. This route has been used for numerous treatments, but with room for progression. Novel respiratory medicines need an additional steadfast and effective dosing regimen to narrow therapeutic directories with a strong need of enhanced deposition in the lungs. Dry powder formulations are of great interest in pulmonary delivery. They provide advantages to traditional suspension and nebulized droplet formulations with ease of administration and simple device design. Using nano carriers, designed with an effective surface modification can be employed for the delivery using dry powder inhalation devices for an effective delivery of the drug moiety within the deep respiratory system, which could be further used for improving drug bioavailability and efficacy, via enhanced recital into the system specifically formulated in a dry powder inhalable device.
Loading....